In studies of RA, aggregates of lymphocytes have consistently been shown to be associated with increased levels of cytokines, chemokines [21–23], and RA-specific autoantibodies [24, 25] and to be predictive of response to TNF inhibitor [24] and rituximab [26]. This evidence concerns the gene TNF and rheumatoid arthritis.